InvestorsHub Logo
Followers 2543
Posts 250732
Boards Moderated 34
Alias Born 05/06/2014

Re: TPX post# 41628

Tuesday, 09/27/2016 5:19:33 PM

Tuesday, September 27, 2016 5:19:33 PM

Post# of 50667
$MCET MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease, fatigue of MS and cancer. The majority owned Xenogenics subsidiary is developing a drug-eluting cardiac stent.

http://www.otcmarkets.com/stock/MCET/profile

investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/